Treatment of hepatitis B - Who, when, and how?

被引：18

作者：

Wong, SN ^{[1
]}

Lok, ASF ^{[1
]}

机构：

[1] Univ Michigan, Med Ctr, Taubman Ctr 3912, Div Gastroenterol, Ann Arbor, MI 48109 USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 2006年 / 166卷 / 01期

关键词：

D O I：

10.1001/archinte.166.1.9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9 / 12

页数：4

共 10 条

[1] Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir [J].

Brunelle, MN ;

Jacquard, AC ;

Pichoud, C ;

Durantel, D ;

Carrouée-Durantel, S ;

Villeneuve, JP ;

Trépo, C ;

Zoulim, F .

HEPATOLOGY, 2005, 41 (06) :1391-1398

[2]

Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI [10.1016/j.gastro.2005.05.053, 10.1053/j.gastro.2005.05.053]

[3] Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B [J].

Lau, GKK ;

Piratvisuth, T ;

Luo, KX ;

Marcellin, P ;

Thongsawat, S ;

Cooksley, G ;

Gane, E ;

Fried, MW ;

Chow, WC ;

Paik, SW ;

Chang, WY ;

Berg, T ;

Flisiak, R ;

McCloud, P ;

Pluck, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26) :2682-2695

[4] Lamivudine for patients with chronic hepatitis B and advanced liver disease [J].

Liaw, YF ;

Sung, JJY ;

Chow, WC ;

Farrell, G ;

Lee, CZ ;

Yuen, H ;

Tanwandee, T ;

Tao, QM ;

Shue, K ;

Keene, ON ;

Dixon, JS ;

Gray, DF ;

Sabbat, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1521-1531

[5] A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B [J].

Lim, SG ;

Ng, TM ;

Kung, N ;

Krastev, Z ;

Volfova, M ;

Husa, P ;

Lee, SS ;

Chan, S ;

Shiffman, ML ;

Washington, MK ;

Rigney, A ;

Anderson, J ;

Mondou, E ;

Snow, A ;

Sorbel, J ;

Guan, R ;

Rousseau, F .

ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (01) :49-56

[6] Long-term safety of lamivudine treatment in patients with chronic hepatitis B [J].

Lok, ASF ;

Lai, CL ;

Leung, N ;

Yao, GB ;

Cui, ZY ;

Schiff, ER ;

Dienstag, JL ;

Heathcote, EJ ;

Little, NR ;

Griffiths, DA ;

Gardner, SD ;

Castiglia, M .

GASTROENTEROLOGY, 2003, 125 (06) :1714-1722

[7] Chronic hepatitis B: Update of recommendations [J].

Lok, ASF ;

McMahon, BJ .

HEPATOLOGY, 2004, 39 (03) :857-861

[8] Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B [J].

Niederau, C ;

Heintges, T ;

Lange, S ;

Goldmann, G ;

Niederau, CM ;

Mohr, L ;

Haussinger, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (22) :1422-1427

[9] Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine [J].

Papatheodoridis, GV ;

Dimou, E ;

Dimakopoulos, K ;

Manolakopoulos, S ;

Rapti, I ;

Kitis, G ;

Tzourmakliotis, D ;

Manesis, E ;

Hadziyannis, SJ .

HEPATOLOGY, 2005, 42 (01) :121-129

[10] A randomised double-blind phase II study of lamivudine (LAM) compared to lamivudine plus adefovir dipivoxil (ADV) for treatment naive patients with chronic hepatitis B (CHB): Week 52 analysis [J].

Sung, JJY ;

Lai, JY ;

Zeuzem, S ;

Chow, WC ;

Heathcote, E ;

Perrillo, R ;

Brosgart, C ;

Woessner, M ;

Scott, SA ;

Campbell, FM .

JOURNAL OF HEPATOLOGY, 2003, 38 :25-26

← 1 →